Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory CohortCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular diseaseRecruitingPhase 12026-09-11NCT04626674

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Hoffmann-La Roche280
Sarepta Therapeutics, Inc.15

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ann & Robert H. Lurie Children's Hospital of ChicagoChicagoUnited States144
Arkansas Children's HospitalLittle RockUnited States82
Children's Hospital of The King's DaughtersNorfolkUnited States87
Duke University Medical CenterDurhamUnited States52
Nationwide Children's HospitalColumbusUnited States309
Neurology Rare Disease CenterFlower MoundUnited States8
Stanford UniversityPalo AltoUnited States161
University of California, DavisSacramentoUnited States3
University of California, Los AngelesLos AngelesUnited States142
University of California, San DiegoLa JollaUnited States25
University of FloridaGainesvilleUnited States144
Washington University in St. LouisSt LouisUnited States79